2019年欧洲生物科技春季大会——第13届年度国际合作会议（2019年3月25日至27日——奥地利维也纳）。

BIO-Europe Spring 2019 - 13th Annual International Partnering Conference (March 25-27, 2019 - Vienna, Austria).

作者信息

Al-Shamahi A

机构信息

Clarivate Analytics, London, UK.

出版信息

Drugs Today (Barc). 2019 May;55(5):345-349. doi: 10.1358/dot.2019.55.5.2996481.

DOI:10.1358/dot.2019.55.5.2996481

PMID:31131844

Abstract

Vienna was the grand setting of the 13th Annual BIO-Europe Spring partnering meeting at the Congress Centre Wien, with receptions at the Hofburg Palace and the Rathaus. Thousands of biopharma executives congregated for one-to-one meetings to discuss collaborations, investment and the in- and outlicensing of assets. The three-day conference agenda included plenary sessions, company presentations, panel discussions, partnering workshops, networking lunches and spotlight sessions. Topics of focus included the Asia-Pacific evolving biopharma landscape, investment and partnering emerging opportunities in metabesity and nonalcoholic steatohepatitis, the biopharma value chain transformation through digital technologies, microbiome therapeutics deals and upcoming trends in European biotech. This report covers highlights from the meeting.

摘要

维也纳是第13届年度生物欧洲春季合作会议的盛大举办地，会议在维也纳会议中心举行，招待会则在霍夫堡皇宫和市政厅举办。数千名生物制药高管齐聚一堂，进行一对一的会议，讨论合作、投资以及资产的引进和授权。为期三天的会议议程包括全体会议、公司展示、小组讨论、合作研讨会、交流午餐会和重点环节。关注的主题包括亚太地区不断发展的生物制药格局、代谢性肥胖和非酒精性脂肪性肝炎领域的投资与合作新机遇、通过数字技术实现的生物制药价值链转型、微生物组治疗交易以及欧洲生物技术的未来趋势。本报告涵盖了会议的要点。